Saving Lives of Cancer Patients by Addressing Cancer-Associated Thrombosis

The European Thrombosis and Haemostasis Alliance (ETHA) welcomes the proposed EU research mission on cancer and firmly believes that to reduce death and disability from cancer across Europe, cancer-associated thrombosis must become ...
Header image

The European Thrombosis and Haemostasis Alliance (ETHA) is an international alliance based in Brussels, Belgium, with 24 member organisations in the field of thrombosis and hemostasis in member states of the European Union (EU) and in the U.S.

The mission of ETHA is to give the thrombosis and hemostasis community a voice and drive prioritisation of thrombosis and hemostasis in the EU patient safety and research programs. With a united focus on raising awareness of bleeding and clotting disorders, ETHA stands together to work with the public as well as decision makers’ to provide input into EU health and patient safety strategies.

To learn more about ETHA’s initial area of priority, read the consensus statement, here.


ETHA Members Attend the 69th Session of the WHO Regional Com...

From 16 – 19 September, members of the European Thrombosis and Haemostasis Alliance will attend the 69th session of the WHO Regional Committee for Europe to review key technical health issues including patient safety. Specific...

Continue reading

ETHA Celebrates World Patient Safety Day on 17 September

On 17 September, the European Thrombosis and Haemostasis Alliance (ETHA) joins the World Health Organization (WHO) and thousands of organizations around the world in an effort to magnify the importance of patient safety. The objecti...

Continue reading
World Thrombosis Day 2019
13 October

World Thrombosis Day (WTD) focuses attention on the often overlooked and misunderstood condition of thrombosis.

More events